β2-Receptor density on mononuclear blood cells in patients suffering from neuroleptic-induced akathisia (NIA)

Biological Psychiatry

Volumn 40, Issue 3, 1996, Pages 203-207

  Botschev, Claudia ^a   Bondy, Brigitta ^b   Hofmann, Marc ^b   Kircher, Tilo ^b   Müller Spahn, Franz ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

mononuclear cells; Neuroleptic induced akathisia; treatment with propranolol; 2 receptor density

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; NEUROLEPTIC AGENT; PROPRANOLOL;

ADULT; AGED; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0030574556     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00354-1     Document Type: Article

References (15)

1. Ackenheil M, Bondy B, Fröhler M (1986): Interactions between catecholamines: Their receptors in blood. Clin Neuropharmacol 9(suppl4):119-121.
2. Adler LA, Duncan E, Kim A, Hemdal P, Rotrosen J, Angrist B (1989a): Akathisia: Selective beta-blockers and rating instruments. Psychopharmacol Bull 3:451-456.
3. Adler LA, Angrist B, Reiter S, Rotrosen J (1989b): Neuroleptic-induced akathisia: A review. Psychopharmacology 97:1-11.
4. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Association.
5. Bondy B, Ackenheil M, Birzle W, Elbers R, Fröhler M (1984): Catecholamines and their receptors in blood: Evidence for alterations in schizophrenia. Biol Psychiatry 19:1377-1393.
6. Bondy B, Ackenheil M, Albus M, Fröhler M, Harrison FJJ (1988): Adrenoceptor sensitivity in blood cells of anxiety patients: A predictor for stress response? In Belmaker RH, Sandler M, Dahlström A (eds), Progress in Catecholamine Research, Part C: Clinical Aspects. New York: Alan R Liss, Inc., pp 393-397.
7. Fleischhacker WW, Roth SD, Kane JM (1990): The pharmacologic treatment of neuroleptic-induced akathisia. J Clin Psychopharmacol 10:12-21.
8. Fleischhacker WW, Miller CH, Schett P, Barnas C, Ehrmann H (1991): The hillside akathisia scale: A reliability comparison of the English and German versions. Psychopharmacology 105:141-144.
9. Gattaz WF, Riederer P, Reynolds GP, Gattaz D, Beckmann H (1983): Dopamine and noradrenaline in the cerebrospinal fluid of schizophrenic patients. Psychiatry Res 8:243-250.
10. Gomes UCR, Shanley BC, Potgieter L, Roux JT (1980): Noradrenergic overactivity in chronic schizophrenia: Evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations. Br J Psychiatry 137:346-351.
11. Lipinski JF, Zubenko GS, Barreira PJ, Cohen BM (1983): Propranolol in the treatment of neuroleptic-induced akathisia. Lancet ii:685-686.
12. Müller-Spahn F, Ackenheil M, Albus M, Botschev C, Naber D, Welter D (1986): Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: Relations to psychopathology. Psychopharmacology 88:190-195.
13. Overall JE, Gorham DR (1976): Brief psychiatric rating scale. In Guy W (ed), Assessment Manual for Psychopharmacology. Rockville, MD: ECDEU, pp 157-169.
14. Sachdev P, Loneragan C (1991): The present status of akathisia. J Nerv Ment Dis 179:381-391.
15. Sternberg DE, Van Kammen DP, Lake CR, Ballenger JC, Marder SR, Bunney WE (1981): The effect of pimozide on CSF norepinephrine in schizophrenia. Am J Psychiatry 138: 1045-1051.